During the 2025 European Society of Cataract and Refractive Surgeons (ESCRS) conference, Past President of the American Society of Cataract and Refractive Surgery (ASCRS) Dr. Vance Thompson was interviewed by Eyewire. Dr. Thompson shared significant information on Avisi’s VisiPlate® and VisiPlate-S products to treat glaucoma. These innovative devices were created to treat varying levels […]
During the 2025 European Society of Cataract and Refractive Surgeons (ESCRS) conference, Past President of the American Society of Cataract and Refractive Surgery (ASCRS) Dr. Vance Thompson was interviewed by Eyewire. Dr. Thompson shared significant information on Avisi’s VisiPlate® and VisiPlate-S products to treat glaucoma. These innovative devices were created to treat varying levels […]
During the 2025 European Society of Cataract and Refractive Surgeons (ESCRS) conference, Past President of the American Society of Cataract and Refractive Surgery (ASCRS) Dr. Vance Thompson was interviewed by Eyewire. Dr. Thompson shared significant information on Avisi’s VisiPlate® and VisiPlate-S products to treat glaucoma. These innovative devices were created to treat varying levels […]
During the 2025 European Society of Cataract and Refractive Surgeons (ESCRS) conference, Past President of the American Society of Cataract and Refractive Surgery (ASCRS) Dr. Vance Thompson was interviewed by Eyewire. Dr. Thompson shared significant information on Avisi’s VisiPlate® and VisiPlate-S products to treat glaucoma. These innovative devices were created to treat varying levels […]
During the 2025 European Society of Cataract and Refractive Surgeons (ESCRS) conference, Past President of the American Society of Cataract and Refractive Surgery (ASCRS) Dr. Vance Thompson was interviewed by Eyewire. Dr. Thompson shared significant information on Avisi’s VisiPlate® and VisiPlate-S products to treat glaucoma. These innovative devices were created to treat varying levels […]
Avisi Technologies, Inc. announced it has secured $10.7 million in a recent Series A financing round to support the SAPPHIRE pivotal clinical trial evaluating its novel glaucoma treatment device: the VisiPlate. Where to begin with this? For a quick refresh on Avisi, click here. As for the focus of this coverage: We’ll start with the VisiPlate—its flagship minimally-invasive bleb surgery […]
